>ABOUT TAKEDA >Message from Top Management

Message from Top Management

Yasuchika Hasegawa, President & CEO

"Better Health, Brighter Future"
Takeda will continue the challenge of becoming a truly global pharmaceutical company that can respond to a diverse array of medical needs to ensure the better health and brighter future of people worldwide.

Takeda’s global footprint and business model have changed substantially following the integration of Nycomed. In light of this, we have formulated “Vision 2020” to articulate our long-term aspiration of where we want the company to be in the year 2020, and initiated a Mid-Range Growth Strategy starting from fiscal 2013 towards the realization of this vision. In Vision 2020, we state that our business objective is to “pursue innovative medicines as well as high-quality branded generics (branded ethical products for which patents have expired), life-saving vaccines, and OTC medicines to help as many people as we can, as soon as we can.” We have defined “Better Health, Brighter Future” as the key message of Vision 2020.

Under the new Mid-Range Growth Strategy, we will create and sustain corporate value by conducting our business according to the core principles of “Globalization,” “Diversity,” and “Innovation,” while also further enhancing our Corporate Social Responsibility activities to respond to the demands of society. The pharmaceutical market has entered a period of major change, significantly affected by fluctuations in the global economy, but Takeda will steadily deliver sustainable growth towards the future by increasing sales, primarily in emerging markets, and ensuring the launch of new products that will contribute to increased profitability from fiscal 2015 onwards.

Takeda’s management team and diverse global workforce of 30,000 employees will make a concerted effort to quickly overcome our decreased profitability due to generic replacement of blockbuster products, all the while remaining committed to the corporate philosophy of “Takedaism” (Integrity: Fairness, Honesty and Perseverance) which lies at the heart of all our business activities. Takeda will continue to meet the expectations of its stakeholders, with the aim of becoming a truly global pharmaceutical company that contributes to better health and a brighter future for all.

Yasuchika Hasegawa